Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2002
05/02/2002WO2001098361A3 Agonist anti-trk-c monoclonal antibodies
05/02/2002WO2001096368A3 Use of coiled-coil structural scaffold to generate structure-specific peptides
05/02/2002WO2001090147A3 Long wavelength engineered fluorescent proteins
05/02/2002WO2001083555A3 Pain signaling molecules
05/02/2002WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand
05/02/2002WO2001068824A3 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
05/02/2002WO2001068708A3 Human and humanized fap-alpha-specific antibodies
05/02/2002WO2001064749A3 Method for preparing anti-mif antibodies
05/02/2002WO2001062923A3 Transporters and ion channels
05/02/2002WO2001061009A3 Polypeptides and nucleic acids encoding same
05/02/2002WO2001061008A3 Polypeptides and nucleic acids encoding same
05/02/2002WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
05/02/2002WO2001051635A3 Novel stra6 polypeptides
05/02/2002WO2001048209A3 Genes identified as required for proliferation of e. coli
05/02/2002WO2001034767A3 22 human secreted proteins
05/02/2002WO2001018172A3 Fibroblast growth factor-like polypeptides
05/02/2002WO2001005997A9 Method for production of tetanus toxin using media substantially free of animal products
05/02/2002WO2001000874A3 Cancer associated antigens and uses therefor
05/02/2002WO2001000237A9 Synthetic peptide immunogens and antibodies thereto
05/02/2002WO2000078972A3 Regulation with binding cassette transporter protein abc1
05/02/2002WO2000077208A9 Gustatory receptors in drosophila
05/02/2002WO2000044395A9 Methods and compositions for modulating fertility
05/02/2002WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
05/02/2002US20020053091 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/02/2002US20020052490 Nucleotide sequences coding polypeptide for use as tool in immunotherapy
05/02/2002US20020052489 Nuclear bindng protein for use as tools in controlling gene transcription
05/02/2002US20020052483 Intestinal trefoil proteins
05/02/2002US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof
05/02/2002US20020052478 Viricides to control virus replication and delay the onset of HIV-1-related disease symptoms; combined the protease cleavage site residues of the Gag/Gag-Pol precursor proteins and the virion-specific feature of Vpr; DNA construct
05/02/2002US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
05/02/2002US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis
05/02/2002US20020052472 ama
05/02/2002US20020052471 Human procalcitonin and the preparation and use thereof
05/02/2002US20020052043 Human G-protein coupled receptors
05/02/2002US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
05/02/2002US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof
05/02/2002US20020052026 Expressing preferential polypeptides in culture; obtain prokaryotic cells, culture, recover preferential polypeptide
05/02/2002US20020052020 Novel orphan receptors
05/02/2002US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity
05/02/2002US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects
05/02/2002US20020051976 Methods and compositions for polypeptide engineering
05/02/2002US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders
05/02/2002US20020051782 Anti-CCR2 antibodies and methods of use therefor
05/02/2002US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment
05/02/2002US20020051760 Method for screening a substance having promoting activity on hair growth
05/02/2002EP1201757A2 Method for preparing water soluble polypeptides
05/02/2002EP1201756A2 Method for preparing water soluble polypeptides
05/02/2002EP1201754A1 Apoptosis-associated factor
05/02/2002EP1201679A2 Angiotensin I-converting enzyme inhibitory substance
05/02/2002EP1201246A2 Use of thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia
05/02/2002EP1201137A1 Cysteine/glycine rich peptides
05/02/2002EP1200622A1 Adenovirus carrying gag gene hiv vaccine
05/02/2002EP1200607A2 Tet repressor-based transcriptional regulatory proteins
05/02/2002EP1200604A1 Production of proteins
05/02/2002EP1200603A1 Production of proteins by autoproteolytic cleavage
05/02/2002EP1200602A1 Dsp-11 dual-specificity map kinase phophatase
05/02/2002EP1200592A2 Mammalian cytokines; related reagents
05/02/2002EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity
05/02/2002EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
05/02/2002EP1200587A2 Receptors and associated proteins
05/02/2002EP1200586A2 Human nervous system-associated proteins
05/02/2002EP1200583A2 Fabrication of beta-pleated sheet proteins with specific binding properties
05/02/2002EP1200581A1 Truncated egf receptor
05/02/2002EP1200561A1 Recombinant stabile cell clone, its production and use thereof
05/02/2002EP1200560A1 Melanin-concentrating hormone receptor
05/02/2002EP1200479A1 Multiple cytokine-antibody complexes
05/02/2002EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein
05/02/2002EP1200476A1 Antitumor antibodies, proteins, and uses thereof
05/02/2002EP1200475A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears
05/02/2002EP1200474A1 Human g-protein coupled receptor
05/02/2002EP1200472A1 Odorant receptors
05/02/2002EP1200469A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
05/02/2002EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family
05/02/2002EP1200124A1 Immunoglobulin fusion proteins
05/02/2002EP1200113A2 Reagents and methods useful for detecting diseases of the prostate
05/02/2002EP1200105A1 Modified factor viii
05/02/2002EP0843722A4 Regulated autocrine growth of mammalian cells
05/02/2002EP0455665B1 Hybrid seed production
05/02/2002CA2464228A1 Vaccine immunotherapy for immune suppressed patients
05/02/2002CA2427312A1 Engineered chimera of protein fragments and methods of use thereof
05/02/2002CA2427085A1 Transmembrane proteins
05/02/2002CA2426767A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/02/2002CA2426405A1 Estrogen receptor alpha variants and methods of detection thereof
05/02/2002CA2426321A1 Mfq-114, a human ajuba like protein
05/02/2002CA2425897A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/02/2002CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
05/02/2002CA2422953A1 Identification and modification of immunodominant epitopes in polypeptides
05/01/2002CN1347449A 芽孢杆菌蛋白生产细胞 Bacillus cell protein production
05/01/2002CN1347421A Antifungal agents isolated from pseudomonas syringae
05/01/2002CN1346891A Process for prepering gamma-polyglutamic acid and polyglutamates
05/01/2002CN1346887A Production and transport of protein
04/2002
04/30/2002US6380376 Purity polypeptides
04/30/2002US6380375 DNA encoding monkey gonadotropin releasing hormone receptor
04/30/2002US6380374 Isolated nucleic acid; culture product
04/30/2002US6380372 Barley gene for Thioredoxin and NADP-thioredoxin reductase
04/30/2002US6380363 Antibodies to the Ob receptor
04/30/2002US6380360 Polycystic kidney disease 1 gene and uses thereof
04/30/2002US6380355 Process for obtaining insulin precursors having correctly bonded cystine bridges
04/30/2002US6380171 Administering antisense nucleic acid having a nucleotide sequence to suppress expression of pro-protein converting enzyme 5 (pc5) gene or to inhibit pc5 activity for reducing restenosis occuring at injured vascular site
04/30/2002US6380160 Gp130 lacking the transmembrane domain